James Lilja, MD
Gynecologic Oncology · Campbell, CANPI 1225081441
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $56,848 of the $73,354 with a category attached, or 77.5%. 46 manufacturers reported payments, led by Stryker at 37.3% of the total. Reporting peaked in 2019 at $21,312 and has fallen 66.7% since, to $7,101 in 2025. Among gynecologic oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $336.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$27K
- Johnson & Johnson$19K
- Roche Molecular Systems, Inc.$10K
- Conmed Corporation$5K
- AbbVie$2K
- Intuitive Surgical$2K
- plus $7K from 40 others
What the payments were for
- Consulting fees$56,84877%
- Speaking & faculty fees$2,0003%
- Travel & lodging$2,9804%
- Food & beverage$9,39713%
- Education$2,1303%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- 1688$8,979
- AIRSEAL$3,676
- DIAGNOSTICS INFORMATION SYSTEMS$3,500
- SPY-PHI SYSTEM$3,174
- 1688 HD 3 CHIP CAMERA$3,150
- Da Vinci Surgical System$2,111
- Orilissa$2,000
- PROCUITY$1,935
- ABC HANDPIECES$1,684
- VCARE$1,650
- SPY TECHNOLOGY$1,350
- SIMSEI LAPAROSCOPIC TRAINER$809
- CoolSeal Generator$800
- HemoBlast Bellows$545
- LYNPARZA$243
- CellerateRx$165
- PreciseTumor$147
- Titan SGS$131
- ALTIS$121
- Laparoscopic Instruments$106
How this compares
$73,354 in reported general payments places this provider in the 90th percentile of 152 gynecologic oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $251 |
| Diclofenac Sodium | 29 | $97 |
| Naproxen | 21 | $86 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Campbell
- John ChanSan Francisco$2M
- Dana ChaseLos Angeles$1.3M
- Ramez EskanderEncinitas$706K
- Krishnansu TewariOrange$495K
- Fabio CappucciniOrange$313K
- Mehdi Moslemi-KebriaUpland$225K
- Amer KaramStanford$168K
- Rebecca BrooksSacramento$133K
- Kenneth KimWest Hollywood$88K
- Oliver DorigoStanford$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.